Effect of Dosage of Metformin on Menstruation and Lipid Profile in Women With Polycystic Ovary Syndrome
Status:
Completed
Trial end date:
2011-02-01
Target enrollment:
Participant gender:
Summary
Polycystic ovarian syndrome (PCOS) is the most common cause of anovulatory infertility and
causes menstrual disruption in 6.6-6.8% of women in reproductive age and is characterized by
insulin resistance, hyperinsulinemia, hyperandrogenism and anovulation. The gaol of this
study was to assess the effects of metformin on menstrual disorders and lipid profile in
women with PCOS in bandarabbas.